Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Trabectedin manufacturers

8 products found

Filters

8 products found

trabectedin

Powder for solution for infusion 0.25 mg, 1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17666
It is inspired by the sea, driven by research, and motivated by the desire to enhance the lives of patients with critical diseases by delivering breakthrough medications. They want to remain the world leader in the discovery, development, and innovation of marine medicinals. For our three commercial medications, they have eight partners who cover over 80 countries. The corporation is based in Western Europe and has subsidiaries in several European markets as well as in the United States.

Manufacturer usually replies in 1 days

trabectedin

Vials 0.25 mg, 1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref. Yondelis® PharmaMar / Janssen
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

trabectedin

Powder for solution for injection 0.25 mg, 1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12922

Manufacturer usually replies in 7 days

trabectedin

Vials 1 mg, 3 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #614
A pharmaceutical manufacturer based in Europe selling its products in Europe and worldwide for 10+ years. Main dosage forms include injectable and oral dosage forms. The company's production lines are EU GMP-compliant. The main therapeutic area is oncology.

Manufacturer usually replies in 7 days

trabectedin

Vials 1 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Comments
Ref. Yondelis® PharmaMar / Janssen
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

trabectedin

Injection 1 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Comments
Available Only For Non-USA
Manufacturer #28190

Manufacturer usually replies in 7 days

trabectedin

Vials, injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17753

Manufacturer usually replies in 10 days

trabectedin

Injection 0.25mg ,1mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
FDA, TGA
Manufacturer #17216

Manufacturer usually replies in 19 days